ImmunoGen, Inc. Announces Webcast Of Presentations At Upcoming Investor Conferences
Published: Nov 11, 2013
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its proprietary antibody-drug conjugate (ADC) technology, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:
Help employers find you! Check out all the jobs and post your resume.